CA Patent

CA2458067C — Use of flibanserin in the treatment of sexual disorders

Assigned to Individual · Expires 2009-02-10 · 17y expired

What this patent protects

The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of disorders of sexual desire.

USPTO Abstract

The invention relates to the use of flibanserin for the preparation of a medicament for the treatment of disorders of sexual desire.

Drugs covered by this patent

Addyi (FLIBANSERIN) · Sprout Pharms

Patent Metadata

Patent number: CA2458067C
Jurisdiction: CA
Classification: —
Expires: 2009-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.